Literature DB >> 16805707

The tumour microenvironment and implications for cancer immunotherapy.

Christian A Petrulio1, Seunghee Kim-Schulze, Howard L Kaufman.   

Abstract

Tumour cells exist in a complex milieu of cellular and non-cellular components comprising fibroblasts, endothelial cells, immune cells and metabolites of cellular respiration. An elaborate interplay between these components and tumour cells exists with implications for immunological recognition of tumour cells. Tumours have been shown to alter their antigen and cytokine profiles, desensitise and impair immune defences, signal fibroblasts to facilitate metastasis, and take advantage of acidic and hypoxic conditions that impede normal cells. This paper aims to review the roles of the stroma, extracellular matrix and chemistry of the microenvironment on tumour growth, with particular emphasis on interactions with the immune system, and to highlight some of the novel therapeutic strategies that target the tumour microenvironment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16805707     DOI: 10.1517/14712598.6.7.671

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  11 in total

1.  Decrease in CD8+ lymphocyte number and altered cytokine profile in human prostate cancer.

Authors:  Gallya Gannot; Annely M Richardson; Jaime Rodriguez-Canales; Peter A Pinto; Maria J Merino; Rodrigo F Chuaqui; John W Gillespie; Michael R Emmert-Buck
Journal:  Am J Cancer Res       Date:  2010-11-10       Impact factor: 6.166

Review 2.  The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers.

Authors:  Qing Zhang; Wen Wen Chen; Xue Sun; Die Qian; Dan Dan Tang; Li Lin Zhang; Mei Yan Li; Lin Yu Wang; Chun-Jie Wu; Wei Peng
Journal:  Int J Biol Sci       Date:  2022-05-16       Impact factor: 10.750

3.  Identification of EpCAM as a molecular target of prostate cancer stroma.

Authors:  Sumana Mukherjee; Annely M Richardson; Jaime Rodriguez-Canales; Kris Ylaya; Heidi S Erickson; Audrey Player; Ernest S Kawasaki; Peter A Pinto; Peter L Choyke; Maria J Merino; Paul S Albert; Rodrigo F Chuaqui; Michael R Emmert-Buck
Journal:  Am J Pathol       Date:  2009-10-22       Impact factor: 4.307

4.  Local IL-21 promotes the therapeutic activity of effector T cells by decreasing regulatory T cells within the tumor microenvironment.

Authors:  Seunghee Kim-Schulze; Hong Sung Kim; Qing Fan; Dae Won Kim; Howard L Kaufman
Journal:  Mol Ther       Date:  2008-11-25       Impact factor: 11.454

5.  Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab.

Authors:  Tímea Balatoni; Andrea Ladányi; Georgina Fröhlich; Kata Czirbesz; Péter Kovács; Gitta Pánczél; Eszter Bence; Vanda Plótár; Gabriella Liszkay
Journal:  Pathol Oncol Res       Date:  2018-09-17       Impact factor: 3.201

6.  Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.

Authors:  Yuk-Wah Tsang; Cheng-Chung Huang; Kai-Lin Yang; Mau-Shin Chi; Hsin-Chien Chiang; Yu-Shan Wang; Gabor Andocs; Andras Szasz; Wen-Tyng Li; Kwan-Hwa Chi
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

7.  Stromal Fibroblasts from the Interface Zone of Triple Negative Breast Carcinomas Induced Epithelial-Mesenchymal Transition and its Inhibition by Emodin.

Authors:  Hsiang-Chi Hsu; Liang-Chih Liu; Hao-Yu Wang; Chao-Ming Hung; Ying-Chao Lin; Chi-Tang Ho; Tzong-Der Way
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

8.  Recombinant heat shock protein 70 in combination with radiotherapy as a source of tumor antigens to improve dendritic cell immunotherapy.

Authors:  Yu-Shan Wang; Shih-Jen Liu; Su-Chen Huang; Chao-Chun Chang; Yi-Chun Huang; Weng-Lam Fong; Mau-Shin Chi; Kwan-Hwa Chi
Journal:  Front Oncol       Date:  2012-10-29       Impact factor: 6.244

9.  Hypoxia promotes tumor growth in linking angiogenesis to immune escape.

Authors:  Salem Chouaib; Yosra Messai; Sophie Couve; Bernard Escudier; Meriem Hasmim; Muhammad Zaeem Noman
Journal:  Front Immunol       Date:  2012-02-23       Impact factor: 7.561

10.  Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein.

Authors:  Sonja I Buschow; Matteo Ramazzotti; Gerold Schuler; Duccio Cavalieri; Carl G Figdor; Inge M J Reinieren-Beeren; Lucie M Heinzerling; Harm Westdorp; Irene Stefanini; Luca Beltrame; Stanleyson V Hato; Eva Ellebaek; Stefanie Gross; Van Anh Nguyen; Georg Weinlich; Jiannis Ragoussis; Dilair Baban; Beatrice Schuler-Thurner; Inge M Svane; Nikolaus Romani; Jonathan M Austyn; I Jolanda M De Vries
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.